Gilead Sciences +

Gilead Sciences

CEO Salary Employees Revenue per Employee Net Income per Employee

Gilead Sciences's CEO Salary

Gilead Sciences's CEO salary and other executives compensation in 2025 was as follows:

Daniel P. O’Day Chairman and Chief Executive Officer at Gilead Sciences, received a total compensation of $28.44 M in 2025.
Dietmar Berger, M.D., Ph.D. Chief Medical Officer at Gilead Sciences, received a total compensation of $13.92 M in 2025.
Johanna Mercier Chief Commercial and Corporate Affairs Officer at Gilead Sciences, received a total compensation of $9.30 M in 2025.
Andrew D. Dickinson Chief Financial Officer at Gilead Sciences, received a total compensation of $8.77 M in 2025.
Deborah H. Telman Former Executive Vice President, Corporate Affairs and General Counsel at Gilead Sciences, received a total compensation of $5.00 M in 2025.

CEO/ Executive salary tells one part of the story. Explore Employee Count Trend, Revenue per Employee, and Profit per Employee to understand workforce scale, and employee productivity.

Daniel P. O’Day Chairman and Chief Executive Officer

Per Year
Per Month
Per Week
Per Day

Daniel P. O’Day Chairman and Chief Executive Officer, at Gilead Sciences, received $1.80 M in base salary, $15.24 M in stock award, and $2.06 M in other compensation, making $28.44 M in total compensation in 2025.

The total compensation was +20.04% up from the previous year, 2024.

Dietmar Berger, M.D., Ph.D. Chief Medical Officer

Per Year
Per Month
Per Week
Per Day

Dietmar Berger, M.D., Ph.D. Chief Medical Officer, at Gilead Sciences, received $969.23 K in base salary, $7.00 M in stock award, and $350.25 K in other compensation, making $13.92 M in total compensation in 2025.

Johanna Mercier Chief Commercial and Corporate Affairs Officer

Per Year
Per Month
Per Week
Per Day

Johanna Mercier Chief Commercial and Corporate Affairs Officer, at Gilead Sciences, received $1.18 M in base salary, $4.56 M in stock award, and $102.98 K in other compensation, making $9.30 M in total compensation in 2025.

The total compensation was +8.03% up from the previous year, 2024.

Andrew D. Dickinson Chief Financial Officer

Per Year
Per Month
Per Week
Per Day

Andrew D. Dickinson Chief Financial Officer, at Gilead Sciences, received $1.12 M in base salary, $4.32 M in stock award, and $70.98 K in other compensation, making $8.77 M in total compensation in 2025.

The total compensation was +8.09% up from the previous year, 2024.

Deborah H. Telman Former Executive Vice President, Corporate Affairs and General Counsel

Per Year
Per Month
Per Week
Per Day

Deborah H. Telman Former Executive Vice President, Corporate Affairs and General Counsel, at Gilead Sciences, received $977.33 K in base salary, $3.07 M in stock award, and $55.48 K in other compensation, making $5.00 M in total compensation in 2025.

The total compensation was -17.58% down from the previous year, 2024.

Executive	2025	2024	2023
Daniel P. O’Day Chairman and Chief Executive Officer	$28.44 M	••••••••	••••••••
Base Salary	$1.80 M	••••••••	••••••••
Incentive Plan Compensation	$4.85 M	••••••••	••••••••
All Other Compensation	$2.06 M	••••••••	••••••••
Stock Award	$15.24 M	••••••••	••••••••
Dietmar Berger, M.D., Ph.D. Chief Medical Officer	$13.92 M	••••••••	••••••••
Base Salary	$969.23 K	••••••••	••••••••
Incentive Plan Compensation	$1.60 M	••••••••	••••••••
All Other Compensation	$350.25 K	••••••••	••••••••
Stock Award	$7.00 M	••••••••	••••••••
Johanna Mercier Chief Commercial and Corporate Affairs Officer	$9.30 M	••••••••	••••••••
Base Salary	$1.18 M	••••••••	••••••••
Incentive Plan Compensation	$2.15 M	••••••••	••••••••
All Other Compensation	$102.98 K	••••••••	••••••••
Stock Award	$4.56 M	••••••••	••••••••
Andrew D. Dickinson Chief Financial Officer	$8.77 M	••••••••	••••••••
Base Salary	$1.12 M	••••••••	••••••••
Incentive Plan Compensation	$1.96 M	••••••••	••••••••
All Other Compensation	$70.98 K	••••••••	••••••••
Stock Award	$4.32 M	••••••••	••••••••
Deborah H. Telman Former Executive Vice President, Corporate Affairs and General Counsel	$5.00 M	••••••••	••••••••
Base Salary	$977.33 K	••••••••	••••••••
Incentive Plan Compensation	-	••••••••	••••••••
All Other Compensation	$55.48 K	••••••••	••••••••
Stock Award	$3.07 M	••••••••	••••••••
Johanna Mercier Chief Commercial Officer	-	••••••••	••••••••
Base Salary	-	••••••••	••••••••
Incentive Plan Compensation	-	••••••••	••••••••
All Other Compensation	-	••••••••	••••••••
Stock Award	-	••••••••	••••••••
Merdad V. Parsey, M.D., Ph.D. Chief Medical Officer	-	••••••••	••••••••
Base Salary	-	••••••••	••••••••
Incentive Plan Compensation	-	••••••••	••••••••
All Other Compensation	-	••••••••	••••••••
Stock Award	-	••••••••	••••••••
Deborah H. Telman Executive Vice President, Corporate Affairs and General Counsel	-	••••••••	••••••••
Base Salary	-	••••••••	••••••••
Incentive Plan Compensation	-	••••••••	••••••••
All Other Compensation	-	••••••••	••••••••
Stock Award	-	••••••••	••••••••

To access the data, Sign up for free

Submit feedback to Bullfincher

Gilead Sciences's CEO Salary

Daniel P. O’Day Chairman and Chief Executive Officer

Dietmar Berger, M.D., Ph.D. Chief Medical Officer

Johanna Mercier Chief Commercial and Corporate Affairs Officer

Andrew D. Dickinson Chief Financial Officer

Deborah H. Telman Former Executive Vice President, Corporate Affairs and General Counsel

Executive Compensation Summary Table

Related

People Also Search For

Submit feedback to Bullfincher